Matches in Wikidata for { <http://www.wikidata.org/entity/Q37175085> ?p ?o ?g. }
- Q37175085 description "article científic" @default.
- Q37175085 description "article scientifique" @default.
- Q37175085 description "articolo scientifico" @default.
- Q37175085 description "artigo científico" @default.
- Q37175085 description "artículu científicu espublizáu en 2016" @default.
- Q37175085 description "bilimsel makale" @default.
- Q37175085 description "scientific article published on April 2016" @default.
- Q37175085 description "vedecký článok" @default.
- Q37175085 description "vetenskaplig artikel" @default.
- Q37175085 description "videnskabelig artikel" @default.
- Q37175085 description "vědecký článek" @default.
- Q37175085 description "wetenschappelijk artikel" @default.
- Q37175085 description "wissenschaftlicher Artikel" @default.
- Q37175085 description "наукова стаття, опублікована у квітні 2016" @default.
- Q37175085 description "научни чланак" @default.
- Q37175085 description "مقالة علمية نشرت في أبريل 2016" @default.
- Q37175085 name "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 name "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 name "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 type Item @default.
- Q37175085 label "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 label "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 label "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 prefLabel "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 prefLabel "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 prefLabel "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 P1433 Q37175085-CECDDED2-32A8-40FA-9DC8-C13A899F1EA3 @default.
- Q37175085 P1476 Q37175085-3F220C81-3521-4DA2-902F-13E0A61F1117 @default.
- Q37175085 P2093 Q37175085-0E24B4BA-CD5F-4C87-A2FD-461FBF200A85 @default.
- Q37175085 P2093 Q37175085-1B92D29A-16E5-4BEE-8B90-A404FA77FB60 @default.
- Q37175085 P2093 Q37175085-2DA16556-6739-49BD-8BF9-EB857C26EA9E @default.
- Q37175085 P2093 Q37175085-6EE47567-2B01-48FE-A932-B870BDDA1DB6 @default.
- Q37175085 P2093 Q37175085-91898C45-3B3D-4258-88A8-61D979F51CF9 @default.
- Q37175085 P2093 Q37175085-B3D6EB08-CD6B-4039-B74F-4F218469175C @default.
- Q37175085 P2093 Q37175085-B7F1E996-7E5A-4A98-9071-6EFD8EB8FB54 @default.
- Q37175085 P2093 Q37175085-E3403974-7676-4190-A323-6435E6969E9D @default.
- Q37175085 P2093 Q37175085-F8ADF000-6964-413F-B1CF-13FAA4EB828A @default.
- Q37175085 P2093 Q37175085-F94C5DC4-6EA9-4366-9D2D-197D5B8F4233 @default.
- Q37175085 P2093 Q37175085-FD66D6DB-D21E-4245-94DA-3BEDD0A7A18B @default.
- Q37175085 P275 Q37175085-409c1824-f8e3-43e6-84b0-b8ac861c771a @default.
- Q37175085 P2860 Q37175085-005414B4-A9A9-4CD6-89F2-934E03453926 @default.
- Q37175085 P2860 Q37175085-03AF6FA1-FEF4-4C86-8E96-1C49747429D3 @default.
- Q37175085 P2860 Q37175085-08FDF5BC-12A4-473D-802B-406AFF22F5A2 @default.
- Q37175085 P2860 Q37175085-0C8CE061-7A63-4C8A-BE49-E22AE4FCC52A @default.
- Q37175085 P2860 Q37175085-1081C6D9-524D-4858-9C13-1046B578470D @default.
- Q37175085 P2860 Q37175085-135CFA94-1823-43F9-A77F-B7B4BE5016FE @default.
- Q37175085 P2860 Q37175085-147A534A-A58E-4230-8019-615FD244B78A @default.
- Q37175085 P2860 Q37175085-1B1D5CDC-0C03-4C7E-9C29-3B4964D4212C @default.
- Q37175085 P2860 Q37175085-2233A603-650A-48B8-BCD6-41ADBC8E634B @default.
- Q37175085 P2860 Q37175085-244D4E7F-41E8-47EB-BFAB-EF09CE4B41F2 @default.
- Q37175085 P2860 Q37175085-282EC7E0-05DA-4692-A234-89A20E61173F @default.
- Q37175085 P2860 Q37175085-2A720EE7-A9CC-481A-AA8E-28A2A9E8CCD3 @default.
- Q37175085 P2860 Q37175085-2DA64F6D-BBA5-412F-ABE4-33C3305ED670 @default.
- Q37175085 P2860 Q37175085-3D4A90C5-EB65-4C91-B4F3-8F4222EF45F4 @default.
- Q37175085 P2860 Q37175085-506DDFEE-ACF4-48DA-8F70-2E234EF022AC @default.
- Q37175085 P2860 Q37175085-5298CC87-9E0B-4E08-955C-422022CEA864 @default.
- Q37175085 P2860 Q37175085-5F491139-B0D8-4104-85F9-CE02056FFCA5 @default.
- Q37175085 P2860 Q37175085-655FB648-6A3A-4F58-B4A5-1351EBEC4010 @default.
- Q37175085 P2860 Q37175085-73584874-1370-4ACC-B117-46AE34F81C06 @default.
- Q37175085 P2860 Q37175085-792BDF9A-2C66-47FF-875E-1EB6D814D3D5 @default.
- Q37175085 P2860 Q37175085-83D6A3AC-7601-44A5-93FB-1A93DC0BE9B0 @default.
- Q37175085 P2860 Q37175085-88091164-7FF5-4167-9D03-E4E2AFEB5F98 @default.
- Q37175085 P2860 Q37175085-8AF285FE-15E5-463D-B367-AD373A7C19B8 @default.
- Q37175085 P2860 Q37175085-B1B49183-DC49-42C5-AB57-90C1CBEAE97A @default.
- Q37175085 P2860 Q37175085-C7484C1D-DA9E-4D75-A358-6A3FE3087927 @default.
- Q37175085 P2860 Q37175085-C75C7BC1-FF65-4291-89D3-D0A47630E021 @default.
- Q37175085 P2860 Q37175085-CCE11D3A-2F27-4C29-A39F-92128C19B426 @default.
- Q37175085 P2860 Q37175085-D03EB261-AD14-4B8A-8086-D892879D6EC0 @default.
- Q37175085 P2860 Q37175085-D7D91FC5-EC7B-4E46-97E4-D6936B7BED26 @default.
- Q37175085 P2860 Q37175085-DC57568B-561A-414F-801D-E6582B02BC9B @default.
- Q37175085 P2860 Q37175085-DFEA1DA8-624C-401D-899C-1A1C970D54C5 @default.
- Q37175085 P2860 Q37175085-E0922A9D-150C-45C0-B400-C8EA15BBB407 @default.
- Q37175085 P2860 Q37175085-E130A5FE-25B5-4272-BB40-AF69450D4EED @default.
- Q37175085 P2860 Q37175085-E148EAC9-BF67-4A78-9993-394D44C77410 @default.
- Q37175085 P2860 Q37175085-E6ADF335-EEB7-4882-A2EE-7A67243C8375 @default.
- Q37175085 P2860 Q37175085-E8992DF8-25CC-4AD5-A57B-703305795098 @default.
- Q37175085 P2860 Q37175085-F103EC87-1D6A-4141-8C39-CAB9400F45E8 @default.
- Q37175085 P2860 Q37175085-F783894B-1B49-4D61-9277-BC6BE3C8F018 @default.
- Q37175085 P2860 Q37175085-F861619A-8CA7-4637-9C40-B39474C34CDC @default.
- Q37175085 P2860 Q37175085-F9576D32-4E5B-4190-8983-439600E9E267 @default.
- Q37175085 P2888 Q37175085-D888F2B8-6189-486F-A8E8-1D399F2C6770 @default.
- Q37175085 P304 Q37175085-DABB0D74-CB34-4E74-95C5-32856B6B794E @default.
- Q37175085 P31 Q37175085-AB1FDA65-8908-45B0-B0A3-1E4AB5BBBC87 @default.
- Q37175085 P356 Q37175085-FBCC910A-3FED-4D13-BBA2-55AAF0086C1F @default.
- Q37175085 P407 Q37175085-1A31FB7E-D082-4E6F-8EA2-8E4F0C659798 @default.
- Q37175085 P433 Q37175085-EF35A133-4A9A-4BDB-ABAB-E61B654FAB35 @default.
- Q37175085 P478 Q37175085-4D5626E2-AAE1-48A3-B4E2-9B2C05C8492A @default.
- Q37175085 P577 Q37175085-20839DE9-5CAD-43B8-AB7E-B703ACE394B3 @default.
- Q37175085 P6216 Q37175085-005fd716-8641-497c-921b-063b7ba8d83a @default.
- Q37175085 P698 Q37175085-3070AB24-40BE-4840-8C28-700A2505EAE5 @default.
- Q37175085 P921 Q37175085-71240E83-D31E-4813-BEDA-BF65CA5CEC39 @default.
- Q37175085 P932 Q37175085-5E39E656-153C-497A-8C59-F4D6FA73CD9E @default.
- Q37175085 P356 BJC.2016.72 @default.
- Q37175085 P698 27115568 @default.
- Q37175085 P1433 Q326309 @default.
- Q37175085 P1476 "Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours" @default.
- Q37175085 P2093 "D Cosgrove" @default.
- Q37175085 P2093 "D Mahalingam" @default.
- Q37175085 P2093 "G Wilding" @default.
- Q37175085 P2093 "J Bruce" @default.